Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Dianthus Therapeutics Inc...

    NASDAQ: DNTH · Real-Time Price · USD
    18.58
    0.62 (3.45%)
    At close: Jun 05, 2025, 3:59 PM
    18.57
    -0.05%
    After-hours: Jun 05, 2025, 04:20 PM EDT
    3.45%
    Bid 17.17
    Market Cap 597.53M
    Revenue (ttm) 6.52M
    Net Income (ttm) -100.73M
    EPS (ttm) -2.83
    PE Ratio (ttm) -6.57
    Forward PE -4.86
    Analyst Buy
    Ask 21.86
    Volume 132,116
    Avg. Volume (20D) 345,038
    Open 17.91
    Previous Close 17.96
    Day's Range 17.58 - 18.74
    52-Week Range 13.37 - 32.27
    Beta 1.37

    About DNTH

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol DNTH
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for DNTH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    11 months ago
    +5.19%
    Dianthus Therapeutics shares are trading higher af... Unlock content with Pro Subscription
    news image

    3 weeks ago · zacks.com

    Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Tops Revenue Estimates

    Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.82 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to loss of $0.54 per share a year ago.

    news image

    2 months ago · zacks.com

    Dianthus Therapeutics, Inc. (DNTH) Soars 6.1%: Is Further Upside Left in the Stock?

    Dianthus Therapeutics, Inc. (DNTH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further s...

    news image

    2 months ago · zacks.com

    Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates

    Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.71 per share a year ago.

    Add to Watchlist